Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Jurnal Sutramas Hang Tuah Medical Journal
SARASWATI LAKSMI DEWI
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Civil Engineering, Building, Construction & Architecture Dentistry Health Professions Medicine & Pharmacology Nursing Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Faktor-Faktor yang Berpengaruh Terhadap Keparahan Infeksi Dengue pada Anak: English PUTU AYUNDA TRISNIA; SARASWATI LAKSMI DEWI; SRI MASYENI
Hang Tuah Medical Journal Vol 23 No 1 (2025): Hang Tuah Medical Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/htmj.v23i1.844

Abstract

Dengue infection is one of the significant global health problems, especially in children. This paper aims to identify factors that affect the severity of dengue infection in the child population. The factors analysed included age, infection status, obesity, viral genome and Ns1 protein titers of dengue. Children who are younger and have an obese nutritional status tend to experience more severe symptoms. In addition, high NS1 titers, viral genomes, and secondary infections also contribute to a higher risk of infection. Detecting warning signs is important because it can be used as a predictor of more severe dengue infection.
PELATIHAN PADA KELUARGA SEBAGAI PENGAWAS MINUM OBAT UNTUK PENCEGAHAN TUBERKULOSIS RESISTEN OBAT MENSUKSESKAN SDGS KETIGA Saraswati Laksmi Dewi
Jurnal Sutramas Vol. 5 No. 01 (2025): Jurnal Sutramas
Publisher : Fakultas Teknik Universitas Warmadewa

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Multidrug-resistant tuberculosis (MDR-TB) remains a public health crisis and threat globally, although the incidence of TB is falling at about 2% per year. The main cause of MDR-TB is the low patient adherence to the lifelong TB regimen. High pill burden with long-course treatment simultaneously induces low adherence of the patient to continue the TB regimen. The patient should take four types of TB drugs for at least 6 months. Family support in the management of TB is absolutely needed to alleviate the incidence of TB multidrug resistance. Drug resistance emerges when anti-TB medicines are used inappropriately, through incorrect prescription by health care providers, poor quality drugs, and patients stopping treatment prematurely. The objective of this program is to educate the TB patient's family in monitoring and assisting the patient in taking the TB drug every day and reporting any side effects of the TB drug as soon as possible to prevent low adherence to the treatment. The planned methods are to train the patient's family to monitor the patient's adherence and to assist with treatment at home.
Perbandingan Tingkat Terendah Trombosit antara Pasien Demam Dengue dan Demam Berdarah Dengue WISNU TRANAYA PUTRA; SRI MASYENI; KOMANG TRISNA SUMADEWI; SARASWATI LAKSMI DEWI
Hang Tuah Medical Journal Vol 23 No 2 (2026): Hang Tuah Medical Journal
Publisher : Universitas Hang Tuah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30649/htmj.v23i2.963

Abstract

Background: Dengue infection remains a major public health problem and is frequently accompanied by thrombocytopenia. The lowest platelet level during illness (thrombocyte nadir) may reflect clinical severity and assist in early risk stratification. Objective: To compare the mean thrombocyte nadir between patients with dengue fever (DF) and dengue hemorrhagic fever (DHF). Methods: A cross-sectional study was conducted using medical record data of 150 hospitalized dengue patients at Sanjiwani Hospital (2022–2024). Dengue was confirmed by IgM anti-dengue testing or NS1 antigen detection. DHF was defined as a ≥20% increase in hematocrit at admission. Patients with a history of idiopathic thrombocytopenic purpura were excluded. Demographic and clinical data were summarized descriptively, and differences in thrombocyte nadir between DF and DHF were analyzed statistically. Results: Of 150 patients, 119 (79.3%) had DF and 31 (20.7%) had DHF. The thrombocyte nadir differed significantly between groups, with DHF demonstrating a lower nadir than DF (p = 0.001). Conclusion: Thrombocyte nadir is significantly lower in DHF compared with DF, supporting the usefulness of serial platelet monitoring to aid severity assessment and clinical surveillance in hospitalized dengue patients.
Co-Authors Komang Trisna Sumadewi Putu Ayunda Trisnia Sri Masyeni, Dewa Ayu Putri WISNU TRANAYA PUTRA